Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-20 4:35 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
26,172 | $8.7737 | $229,624 | 225,740 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
21,704 | $7.225 | $156,811 | 251,912 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
21,172 | $8.2182 | $173,996 | 273,616 (Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:48 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
48,847 | $4.5556 | $222,527 | 294,788 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:29 am |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
22,528 | $6.4726 | $145,815 | 330,735 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:35 am |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
20,293 | $5.9734 | $121,218 | 353,263 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
15,985 | $1.878 | $30,020 | 40,985 (Direct) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:09 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
25,000 | $8 | $200,000 | 25,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
525,000 | $0 | 525,000 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-21 3:07 pm |
N/A 2030-10-10 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
12,900 | $0 | 2,107,603 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-21 3:07 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
12,900 | $1.55 | 2,107,603 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
43,443 | $0.9 | 373,556 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,108 | $0 | 416,999 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:10 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
195,906 | $0 | 220,906 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 6:35 pm |
N/A 2032-02-28 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
330,000 | $0 | 330,000 (Direct) |
View |
Ownership |
2021-07-26 9:22 pm |
N/A 2030-10-09 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter President & CEO |
0 | $0 | 2,073,012 (Direct) |
View |